Krystal Biotech, Inc. (KRYS)
NASDAQ$179.38
Market Cap
$5.17B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
671 of 924
Rank in Industry
382 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
KRYS Insider Trading Activity
KRYS Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $75,025,876 | 10 | 100 |
Related Transactions
| ROMANO KATHRYN | Chief Accounting Officer | 0 | $0 | 1 | $131,415 | $-131,415 |
| Gangolli Julian S | director | 0 | $0 | 1 | $3.28M | $-3.28M |
| Krishnan Krish S | President and CEO | 0 | $0 | 4 | $35.81M | $-35.81M |
| Krishnan Suma | President, R&D | 0 | $0 | 4 | $35.81M | $-35.81M |
About Krystal Biotech, Inc.
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other …
Insider Activity of Krystal Biotech, Inc.
Over the last 12 months, insiders at Krystal Biotech, Inc. have bought $0 and sold $75.03M worth of Krystal Biotech, Inc. stock.
On average, over the past 5 years, insiders at Krystal Biotech, Inc. have bought $0 and sold $42.71M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 50,000 shares for transaction amount of $1M was made by Krishnan Suma (Chief Operating Officer) on 2018‑10‑18.
List of Insider Buy and Sell Transactions, Krystal Biotech, Inc.
| 2025-03-13 | Sale | Krishnan Suma | President, R&D | 50,000 0.174% | $177.79 | $8.89M | +1.13% | |
| 2025-03-13 | Sale | Krishnan Krish S | President and CEO | 50,000 0.174% | $177.79 | $8.89M | +1.13% | |
| 2025-02-27 | Sale | ROMANO KATHRYN | Chief Accounting Officer | 750 0.0026% | $175.22 | $131,415 | +3.40% | |
| 2024-12-13 | Sale | Krishnan Suma | President, R&D | 50,000 0.1739% | $164.80 | $8.24M | -2.52% | |
| 2024-12-13 | Sale | Krishnan Krish S | President and CEO | 50,000 0.1739% | $164.80 | $8.24M | -2.52% | |
| 2024-09-12 | Sale | Krishnan Suma | President, R&D | 50,000 0.1759% | $197.77 | $9.89M | -10.07% | |
| 2024-09-12 | Sale | Krishnan Krish S | President and CEO | 50,000 0.1759% | $197.77 | $9.89M | -10.07% | |
| 2024-06-11 | Sale | Krishnan Suma | President, R&D | 50,000 0.1734% | $175.76 | $8.79M | +1.12% | |
| 2024-06-11 | Sale | Krishnan Krish S | President and CEO | 50,000 0.1734% | $175.76 | $8.79M | +1.12% | |
| 2024-05-20 | Sale | Gangolli Julian S | director | 20,000 0.0699% | $164.13 | $3.28M | +8.56% | |
| 2024-03-11 | Sale | Krishnan Suma | President, R&D | 50,000 0.1773% | $170.95 | $8.55M | +3.95% | |
| 2024-03-11 | Sale | Krishnan Krish S | President and CEO | 50,000 0.1773% | $170.95 | $8.55M | +3.95% | |
| 2024-02-28 | Sale | ROMANO KATHRYN | Chief Accounting Officer | 12,200 0.0438% | $165.94 | $2.02M | +8.16% | |
| 2024-02-28 | Sale | ROMANO KATHRYN | Chief Accounting Officer | 11,997 0.0431% | $165.88 | $1.99M | +8.16% | |
| 2024-02-28 | Sale | ROMANO KATHRYN | Chief Accounting Officer | 10,600 0.0381% | $166.10 | $1.76M | +8.16% | |
| 2024-02-26 | Sale | ROMANO KATHRYN | Chief Accounting Officer | 8,087 0.025% | $136.91 | $1.11M | +12.24% | |
| 2024-01-22 | Sale | Romano Kathryn | Chief Accounting Officer | 2,500 0.0088% | $130.00 | $325,000 | +33.98% | |
| 2023-12-11 | Sale | Krishnan Suma | President, R&D | 50,000 0.1761% | $105.67 | $5.28M | +65.57% | |
| 2023-12-11 | Sale | Krishnan Krish S | President and CEO | 50,000 0.1761% | $105.67 | $5.28M | +65.57% | |
| 2023-09-11 | Sale | Krishnan Suma | President, R&D | 50,000 0.1769% | $127.23 | $6.36M | +23.51% |
Total: 84
*Gray background shows transactions not older than one year
Insider Historical Profitability
54.58%
| Krishnan Krish S | President and CEO | 1463711 5.0813% | $262.56M | 3 | 26 | +37.28% |
| Krishnan Suma | President, R&D | 1463711 5.0813% | $262.56M | 4 | 29 | +56.29% |
| JANNEY DANIEL | director | 107362 0.3727% | $19.26M | 1 | 8 | +2.09% |
| NORBY R DOUGLAS | director | 9000 0.0312% | $1.61M | 1 | 0 | +106.7% |
| Riley Antony A | Chief Financial Officer | 2800 0.0097% | $502,264.00 | 1 | 0 | +100% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$159,914,414 | 243 | 18.52% | $5.91B | |
$52,263,649 | 70 | 1.18% | $4.36B | |
$415,105,240 | 19 | -14.04% | $6.27B | |
$11,859,102 | 17 | 18.62% | $5.25B | |
$1,279,017 | 16 | 51.12% | $5.94B |
KRYS Institutional Investors: Active Positions
| Increased Positions | 135 | +39.94% | 1M | +4.95% |
| Decreased Positions | 152 | -44.97% | 2M | -6.2% |
| New Positions | 39 | New | 305,428 | New |
| Sold Out Positions | 53 | Sold Out | 342,209 | Sold Out |
| Total Postitions | 321 | -5.03% | 28M | -1.25% |
KRYS Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Fmr Llc | $810,431.00 | 14.88% | 4.31M | +21,133 | +0.49% | 2024-12-31 |
| Blackrock, Inc. | $757,803.00 | 13.91% | 4.03M | +40,749 | +1.02% | 2024-12-31 |
| Vanguard Group Inc | $540,746.00 | 9.93% | 2.88M | +28,707 | +1.01% | 2024-12-31 |
| Avoro Capital Advisors Llc | $493,851.00 | 9.07% | 2.63M | +6,600 | +0.25% | 2024-12-31 |
| State Street Corp | $240,268.00 | 4.41% | 1.28M | -173,836 | -11.96% | 2024-12-31 |
| Capital World Investors | $165,167.00 | 3.03% | 879,203 | +120 | +0.01% | 2024-12-31 |
| Frazier Life Sciences Management, L.P. | $148,120.00 | 2.72% | 788,460 | -200,000 | -20.23% | 2024-12-31 |
| Redmile Group, Llc | $141,491.00 | 2.6% | 753,175 | -57,070 | -7.04% | 2024-12-31 |
| Geode Capital Management, Llc | $111,137.00 | 2.04% | 591,596 | -35 | <0.01% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $110,574.00 | 2.03% | 588,599 | -11,662 | -1.94% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.